首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel
【24h】

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel

机译:以色列耐氟康唑的念珠菌血流分离株在医院和住院服务中的分布

获取原文
获取原文并翻译 | 示例
           

摘要

The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.
机译:耐氟康唑的念珠菌(FRC)的出现令人担忧,但对于不同医院环境中的药敏模式知之甚少。我们前瞻性地分析了以色列18个医疗中心(6个三级医疗和12个社区医院)的念珠菌血流分离株。该研究包括444例念珠菌血症(450例患者特异性分离株,对氟康唑耐药8.5%)。机构FRC血流感染率与每年住院天数相关,并且与血液学/肿瘤学服务的存在和活动密切相关。克鲁斯假丝酵母和耐氟康唑的光滑假丝酵母仅在拥有600张以上床位的医院中感染。这些发现表明,经验性的抗真菌策略应适合医院环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号